Status:
NOT_YET_RECRUITING
HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM)
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Collaborating Sponsors:
University Hospital, Rouen
Centre Pasteur du Cameroun
Conditions:
HIV Infection
Eligibility:
All Genders
21+ years
Brief Summary
The aim of the study is to study the genotypic characteristics of HIV-1 non-M circulating in the whole Cameroon and their genetic evolution.
Detailed Description
HIV-1 is divided four distinct groups: M (major) which represents the pandemic strains while others groups O (outlier), N (non M, non O) and P are called non-M variants. Group O (HIV-O) is more diverg...
Eligibility Criteria
Inclusion
- All available samples tested positive for HIV during the national Health survey of Cameroon in 2011 And 2018
- All Individuals who came to Centre Pasteur in Yaoundé or Garoua for HIV screening or viral load monitoring.
Exclusion
- Insufficient quantity or degraded Dried Blood Spot samples
- All HIV-positive individuals aged less than 21 years, infected with a Group M HIV-1 virus, or those who refused to participate in the study
Key Trial Info
Start Date :
June 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT06913959
Start Date
June 30 2025
End Date
July 1 2027
Last Update
April 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.